Geneos Wealth Management Inc. Amneal Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $780 - $977	200 New	200 $0
Q4 2021 Feb 09, 2022	SELL	$3.95 - $5.85 $793 - $1,175	-201 Closed	0 $0
Q2 2021 Jul 08, 2021	SELL	$5.12 - $6.82 $1,643 - $2,189	-321 Reduced 61.49%	201 $1,000
Q1 2021 Jun 17, 2021	BUY	$4.74 - $7.38 $1,526 - $2,376	322 Added 161.0%	522 $2,000
Q4 2020 May 19, 2021	BUY	$3.95 - $5.42 $790 - $1,084	200 New	200 $1,000
Q3 2019 Sep 07, 2021	SELL	$2.29 - $7.1 $458 - $1,420	-200 Closed	0 $0
Q2 2018 Sep 07, 2021	BUY	$13.95 - $20.2 $2,790 - $4,040	200 New	200 $3,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.